Nasdaq Verv News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq verv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Verv Today - Breaking & Trending Today

Verve Therapeutics (NASDAQ:VERV) Hits New 52-Week Low at $6.05

Shares of Verve Therapeutics, Inc. (NASDAQ:VERV – Get Free Report) hit a new 52-week low on Thursday . The stock traded as low as $6.05 and last traded at $6.22, with a volume of 247043 shares trading hands. The stock had previously closed at $6.58. Wall Street Analyst Weigh In Several research analysts have weighed […] ....

United States , Stifel Nicolaus , Royal Bank , Daiwa Securities Group Inc , Newbridge Financial Services Group Inc , Quest Partners , Financial Services Group Inc , Verve Therapeutics Inc , Verve Therapeutics , Get Free Report , Services Group , Financial Services Group , Securities Group , Verve Therapeutics Daily , Nasdaq Verv ,

Insider Selling: Verve Therapeutics, Inc. (NASDAQ:VERV) Insider Sells $12,475.36 in Stock

Verve Therapeutics, Inc. (NASDAQ:VERV – Get Free Report) insider Joan Nickerson sold 1,514 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $8.24, for a total transaction of $12,475.36. Following the completion of the transaction, the insider now owns 8,659 shares in […] ....

United States , Stifel Nicolaus , Joan Nickerson , Quest Partners , Verve Therapeutics Inc , Verve Therapeutics Company Profile , Penserra Capital Management , Royal Bank , Financial Services Group Inc , Newbridge Financial Services Group Inc , Verve Therapeutics , Get Free Report , Services Group , Financial Services Group , Verve Therapeutics Daily , Nasdaq Verv , Insider Trading , Nsider Trades ,

Verve Therapeutics Announces Inducement Grants under Nasdaq

BOSTON, March 28, 2024 (GLOBE NEWSWIRE) Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of. ....

United States , Jen Robinson , Verve Therapeutics Inc , Stock Incentive Plan , Nasdaq Listing Rule , Verve Therapeutics , Nasdaq Verv , Verve Therapeutics ,

Verve Therapeutics' (VERV) Outperform Rating Reiterated at Royal Bank of Canada

Verve Therapeutics (NASDAQ:VERV – Get Free Report)‘s stock had its “outperform” rating reissued by Royal Bank of Canada in a research note issued to investors on Wednesday, Benzinga reports. They presently have a $35.00 target price on the stock. Royal Bank of Canada’s price objective indicates a potential upside of 89.70% from the company’s previous […] ....

United States , William Blair , Voya Investment Management , Royal Bank , Group Plc , Ameritas Investment Partners Inc , Verve Therapeutics Inc , American International Group Inc , Verve Therapeutics , Get Free Report , International Group , General Group Plc , Investment Management , Ameritas Investment Partners , Investment Partners , Verve Therapeutics Daily , Nasdaq Verv , Reiterated Rating , Royal Bank Of Canada ,

Verve Therapeutics (NASDAQ:VERV) Announces Earnings Results

Verve Therapeutics (NASDAQ:VERV – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.69) earnings per share for the quarter, topping the consensus estimate of ($0.83) by $0.14, Briefing.com reports. The company had revenue of $5.14 million during the quarter, compared to analyst estimates of $3.95 million. Verve Therapeutics had a […] ....

Hong Kong , William Blair , Penserra Capital Management , Ensign Peak Advisors Inc , Hong Kong Ltd , Verve Therapeutics Inc , Royal Bank , Verve Therapeutics , Get Free Report , Kong Ltd , Capital Management , Peak Advisors Inc , Quantbot Technologies , Verve Therapeutics Daily , Nasdaq Verv ,